Stem Cell Research Enhancement Act

From Wikipedia, the free encyclopedia

Stem Cell Research Enhancement Act was the name of two similar bills that both passed through the United States House of Representatives and Senate, but were both vetoed by President George W. Bush and were not enacted into law.

Stem Cell Research Enhancement Act of 2005[]

The Stem Cell Research Enhancement Act of 2005 (H.R. 810) was the first bill ever vetoed by United States President George W. Bush, more than five years after his inauguration. The bill, which passed both houses of Congress, but by less than the two-thirds majority needed to override the veto, would have allowed federal funding of stem cell research on new lines of stem cells derived from discarded human embryos created for fertility treatments.[1]

The bill passed House of Representatives by a vote of 238 to 194 on May 24, 2005.,[2] then passed the Senate by a vote of 63 to 37 on July 18, 2006. President Bush vetoed the bill on July 19, 2006. The House of Representatives then failed to override the veto (235 to 193) on July 19, 2006.[1]

Stem Cell Research Enhancement Act of 2007[]

The Stem Cell Research Enhancement Act of 2007 (S. 5), was proposed federal legislation that would have amended the Public Health Service Act to provide for human embryonic stem cell research. It was similar in content to the vetoed Stem Cell Research Enhancement Act of 2005.

The bill passed the Senate on April 11, 2007 by a vote of 63-34, then passed the House on June 7, 2007 by a vote of 247-176. President Bush vetoed the bill on June 19, 2007,[3] and an override was not attempted.

Stem Cell Research Enhancement Act of 2009[]

The bill was re-introduced in the 111th Congress. It was introduced in the House by Representative Diana DeGette (D-CO) on February 4, 2009.[4] A Senate version was introduced by Tom Harkin (D-IA) on February 26, 2009.[5] The House bill had 113 co-sponsors [6] and the Senate 10 co-sponsors, as of November 20, 2009.[7]

Legislative history[]

Congress Short title Bill number(s) Date introduced Sponsor(s) # of cosponsors Latest status
111th Congress Stem Cell Research Enhancement Act of 2009 H.R. 873 February 4, 2009 Rep. Diana DeGette (D-CO) 113 Referred to the House Committee on Energy and Commerce.
S. 487 February 26, 2009 Sen. Tom Harkin (D-IA) 10 Read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions.
110th Congress Stem Cell Research Enhancement Act of 2007 H.R. 3 January 5, 2007 Rep. Diana DeGette (D-CO) 217 Passed the House (253–174)
S. 5 January 4, 2007 Sen. Harry Reid (D-NV) 41 Passed the Senate (63–34). Passed the House (247–176). Vetoed by President.
109th Congress Stem Cell Research Enhancement Act of 2005 H.R. 810 February 15, 2005 Rep. Michael Castle (R-DE) 200 Passed the House (238–194). Passed the Senate (63–37). Vetoed by President. Veto Override Failed in the House (235–193).
S. 471 February 28, 2005 Sen. Arlen Specter (R-PA) 43 Read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions.

References[]

  1. ^ a b Mlsna, Lucas J. (2010). "Stem Cell Based Treatments and Novel Considerations for Conscience Clause Legislation". Indiana Health Law Review. United States: Indiana University Robert H. McKinney School of Law. 8 (2): 471–496. ISSN:1549-3199. LCCN:2004212209. OCLC:OCLC 54703225.
  2. ^ govtrack.us
  3. ^ "Senate Approves Embryonic Stem Cell Bill", David Espo, Associated Press, April 12, 2007
  4. ^ "Stem Cell Research Enhancement Act of 2009 (2009 - H.R. 873)".
  5. ^ "Stem Cell Research Enhancement Act of 2009 (2009 - S. 487)".
  6. ^ http://thomas.loc.gov/cgi-bin/bdquery/z?d111:HR00873:%7C/bss/111search.html%7C[permanent dead link]
  7. ^ http://thomas.loc.gov/cgi-bin/bdquery/z?d111:SN00487:%7C/bss/111search.html%7C[permanent dead link]

External links[]

Retrieved from ""